This discovery provides researchers with an exciting fresh avenue to explore as they search for a highly effective treatment. Primary liver tumor represents one of the most common malignancies in the world and makes up about almost 1.25 million deaths annually. In the US, liver disease is among the ten major causes of death. The management of hepatic tumors presents a challenging problem. Advanced preoperative imaging evaluation is paramount in determining appropriate treatment, and needs the participation of a multidisciplinary team of surgeons, oncologists, hepatologists, and interventional radiologists focusing on liver malignancy. It provides a forward thinking toolset for real-time interactive evaluation and volumetric quantification of liver, liver lobes, hepatics vessels and lesions.Related StoriesAntibiotic resistance possibly threatens the basic safety and efficacy of surgical treatments and immunosuppression therapiesVirginia Tech researchers discover new remedies to target antibiotic-resistant bacteriaNew research uncovers antibiotic prescription developments across EnglandA total of 310 patients were signed up for the study and randomized to get either amoxicillin/clavulanate or placebo 3 x daily for eight times. All participants were in least 40 years had and old a spirometrically-confirmed medical diagnosis of mild-to-moderate COPD.